Bilaketaren emaitzak - Torayuki Okuyama
- Erakusten 1 - 20 emaitzak -- 20
-
1
The role of lipoxygenases in pathophysiology; new insights and future perspectives nork Ryuichi Mashima, Torayuki Okuyama
Argitaratua 2015Revisão -
2
Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses nork Yuji Sato, Torayuki Okuyama
Argitaratua 2020Revisão -
3
-
4
-
5
-
6
-
7
-
8
Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial nork Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai, Kohtaro Minami, Tatsuyoshi Yamamoto, Hiroyuki Sonoda, Mariko Yamaoka, Katsuhiko Tachibana, Tohru Hirato, Yuji Sato
Argitaratua 2018Artigo -
9
-
10
A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II nork Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai, Kimitoshi Nakamura, Tatsuyoshi Yamamoto, Mariko Yamaoka, Toshiaki Ikeda, Sairei So, Kazunori Tanizawa, Hiroyuki Sonoda, Yuji Sato
Argitaratua 2020Artigo -
11
Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms nork Sanae Haga, Keita Terui, Hui Qi Zhang, Shin Enosawa, Wataru Ogawa, Hiroshi Inoue, Torayuki Okuyama, Kiyoshi Takeda, Shizuo Akira, Tetsuya Ogino, Kaikobad Irani, Michitaka Ozaki
Argitaratua 2003Artigo -
12
Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms nork Sanae Haga, Keita Terui, Hui Qi Zhang, Shin Enosawa, Wataru Ogawa, Hiroshi Inoue, Torayuki Okuyama, Kiyoshi Takeda, Shizuo Akira, Tetsuya Ogino, Kaikobad Irani, Michitaka Ozaki
Argitaratua 2003Artigo -
13
Mucolipidosis II and III alpha/beta: mutation analysis of 40 Japanese patients showed genotype–phenotype correlation nork Takanobu Otomo, Takeshi Muramatsu, Tohru Yorifuji, Torayuki Okuyama, Hiroki Nakabayashi, Toshiyuki Fukao, Toshihiro Ohura, Makoto Yoshino, Akemi Tanaka, Nobuhiko Okamoto, Koji Inui, Keiichi Ozono, Norio Sakai
Argitaratua 2009Artigo -
14
Sex-Determining Gene(s) on Distal 9p: Clinical and Molecular Studies in Six Cases* nork Koji Muroya, Torayuki Okuyama, Keiji Goishi, Yoshifumi Ogiso, Shin Fukuda, Junji Kameyama, Hirokazu Sato, Yoshimi Suzuki, Hiroshi Terasaki, Hiroki Gomyo, Keiko Wakui, Yoshimitsu Fukushima, Tsutomu Ogata
Argitaratua 2000Artigo -
15
Protein-Tyrosine Phosphatase, Nonreceptor Type 11 Mutation Analysis and Clinical Assessment in 45 Patients with Noonan Syndrome nork Rie Yoshida, Tomonobu Hasegawa, Yukihiro Hasegawa, Toshiro Nagai, Eiichi Kinoshita, Yoko Tanaka, Hirokazu Kanegane, Kenji Ohyama, Toshikazu Onishi, Kunihiko Hanew, Torayuki Okuyama, Reiko Horikawa, Toshiaki Tanaka, Tsutomu Ogata
Argitaratua 2004Artigo -
16
Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry nork Lorne A. Clarke, Roberto Giugliani, Nathalie Guffon, Simon Jones, Hillary A. Keenan, María Verónica Muñoz‐Rojas, Torayuki Okuyama, David Viskochil, Chester B. Whitley, Frits A. Wijburg, Joseph Muenzer
Argitaratua 2019Artigo -
17
Cytochrome P450 Oxidoreductase Gene Mutations and Antley-Bixler Syndrome with Abnormal Genitalia and/or Impaired Steroidogenesis: Molecular and Clinical Studies in 10 Patients nork Maki Fukami, Reiko Horikawa, Toshiro Nagai, Toshiaki Tanaka, Yasuhiro Naiki, Naoko Sato, Torayuki Okuyama, Hideo Nakai, Shun Soneda, Katsuhiko Tachibana, Nobutake Matsuo, Seiji Sato, Keiko Homma, Gen Nishimura, Tomonobu Hasegawa, Tsutomu Ogata
Argitaratua 2005Artigo -
18
Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: an Integrated Analysis of Preclinical and Clinical Data nork Roberto Giugliani, Ana Maria Martins, Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai, Kimitoshi Nakamura, Hideto Morimoto, Kohtaro Minami, Tatsuyoshi Yamamoto, Mariko Yamaoka, Toshiaki Ikeda, Sairei So, Kazunori Tanizawa, Hiroyuki Sonoda, Mathias Schmidt, Yuji Sato
Argitaratua 2021Pré-impressão -
19
Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data nork Roberto Giugliani, Ana Maria Martins, Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai, Kimitoshi Nakamura, Hideto Morimoto, Kohtaro Minami, Tatsuyoshi Yamamoto, Mariko Yamaoka, Toshiaki Ikeda, Sairei So, Kazunori Tanizawa, Hiroyuki Sonoda, Mathias Schmidt, Yuji Sato
Argitaratua 2021Artigo -
20
Mutations in SERPINB7, Encoding a Member of the Serine Protease Inhibitor Superfamily, Cause Nagashima-type Palmoplantar Keratosis nork Akiharu Kubo, Aiko Shiohama, Takashi Sasaki, Kazuhiko Nakabayashi, Hiroshi Kawasaki, Toru Atsugi, Showbu Sato, Atsushi Shimizu, Shuji Mikami, Hideaki Tanizaki, M Uchiyama, Tatsuo Maeda, Taisuke Ito, Jun‐ichi Sakabe, Toshio Heike, Torayuki Okuyama, Rika Kosaki, Kenjiro Kosaki, Jun Kudoh, Kenichiro Hata, Akihiro Umezawa, Y. Tokura, Akira Ishiko, Hironori Niizeki, Kenji Kabashima, Yoshihiko Mitsuhashi, Masayuki Amagai
Argitaratua 2013Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Biology
Medicine
Gene
Internal medicine
Disease
Enzyme replacement therapy
Biochemistry
Genetics
Pharmacology
Chemistry
Enzyme
Hurler syndrome
Mutation
Compound heterozygosity
Missense mutation
Molecular biology
Mucopolysaccharidosis
Pathology
Adverse effect
Cell biology
Endocrinology
Exon
Gastroenterology
Hunter syndrome
Mucopolysaccharidosis I
Mucopolysaccharidosis type I
Mucopolysaccharidosis type II
Newborn screening
Pediatrics
Phenotype